# Adversarial review log — llps-nuclear-bodies (revised edition)

Authoring model: **Sol 6.1**. Adversarial reviewer: **Claude Opus 5.5 (Anthropic)**. Date: **2026-10-14**.
Round 2; group 12 of `NEW_REVIEW_INVENTORY_2026-10-14.json`. Canonical copy is the 9 October 2026 revised edition.

## Summary

| Item | Value |
|---|---|
| Level before | Γ — Mechanistically plausible, partial system support / Moderate |
| Level after | Γ — Mechanistically plausible, partial system support / Moderate (unchanged) |
| Findings: Critical | 0 |
| Findings: Major | 2 |
| Findings: Minor | 2 |
| Findings: Editorial | 1 |
| Rejected findings | 9 |
| PMIDs checked / failed | 63 / 0 |
| Load-bearing claims spot-checked | 12 |
| Validator | PASS (0 fail, 1 warn, 31 pass) — `v5.claim_form` WARN only; identical before and after. |
| Approval | **Approved as revised.** |

## Findings

Full table (AR-1 to AR-5), the nine rejected findings and the residual limitations are in the `## ADVERSARIAL REVIEW AND APPROVAL` section of `llps-nuclear-bodies.review.md`. In brief:

- **AR-1 (Major, revision regression).** The 9 October integration spliced "The earlier adversarial approval refers to its original edition" into a case that has no earlier adversarial approval. Verified against `hsef_v53_popularity_ranks_31_35_2026-10-08/llps-nuclear-bodies/llps-nuclear-bodies.review.md`, which has no approval section or banner. Rescoped in both the review and `consensus-addendum.md`.
- **AR-2 (Major, momentum).** "Decisive work underway" corrected to "Mechanistic only": every item in the artifact is a completed publication, the review asserts no recruiting study, and none of the named work attempts the liquidity-only rescue the review itself identifies as the decisive boundary check.
- **AR-3 (Minor).** Confidence rationale cited reviewer access depth; rewritten on evidence-density and reproducibility grounds. Band stands at Moderate under the lead two-step test, because the review documents real evidence-quality reservations (probe- and timescale-dependent measurements, expressed optogenetic constructs, a shared paraspeckle platform, mixed liquid and partly solid phases, demonstrated non-specificity of hexanediol and classical FRAP).
- **AR-4 (Minor).** Divergence "Contested" given its required artifact naming the two conflicting framings.
- **AR-5 (Editorial).** Ten instances of "erratum30849377" / "erratum29654784" repaired to "erratum PMID3084937..." form across the review and the score card.

## Strings for the lead to propagate to package-level files

| Old | New |
|---|---|
| `Decisive work underway` (llps-nuclear-bodies row, Momentum column) | `Mechanistic only` |

No level, confidence, role, source count or claim count changed. The earlier edition at `hsef_v53_popularity_ranks_31_35_2026-10-08/llps-nuclear-bodies/` is a divergent copy and was **not** overwritten.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved. — Claude Opus 5.5 (Anthropic), 2026-10-14.